Methods
With institutional approval, all BP-RMS patients treated by interstitial
HDR-BT from 2014 to 2019 were included. Case records were prospectively
collected. Patients were treated on the EpSSG RMS 2005 protocol[12]:
after 3 cycles of chemotherapy (iFosfamide, Vincristine, Actinomycin D
with or without Doxorubicin), the response to chemotherapy is appraised
and local therapy options are considered on a case by case basis.